|
Originally published In Press as doi:10.1074/jbc.M204539200 on June 17, 2002
J. Biol. Chem., Vol. 277, Issue 35, 31972-31979, August 30, 2002
A Single Cell Density-sensing Factor Stimulates Distinct Signal
Transduction Pathways through Two Different Receptors*
William J.
Deery,
Tong
Gao,
Robin
Ammann, and
Richard H.
Gomer
From the Howard Hughes Medical Institute, Department of
Biochemistry and Cell Biology, Rice University,
Houston, Texas 77005-1892
Received for publication, May 8, 2002, and in revised form, June 13, 2002
 |
ABSTRACT |
In Dictyostelium discoideum, cell
density is monitored by levels of a secreted protein, conditioned
medium factor (CMF). CMFR1 is a putative CMF receptor necessary for
CMF-induced G protein-independent accumulation of the SP70 prespore
protein but not for CMF-induced G protein-dependent
inositol 1,4,5-trisphosphate production. Using recombinant fragments of
CMF, we find that stimulation of the inositol 1,4,5-trisphosphate
pathway requires amino acids 170-180, whereas SP70 accumulation does
not, corroborating a two-receptor model. Cells lacking CMFR1 do not
aggregate, due to the lack of expression of several important early
developmentally regulated genes, including gp80. Although
many aspects of early developmental cAMP-stimulated signal transduction
are mediated by CMF, CMFR1 is not essential for cAMP-stimulated cAMP
and cGMP production or Ca2+ uptake, suggesting the
involvement of a second CMF receptor. Exogenous application of
antibodies against either the region between a first and second or a
second and third possible transmembrane domain of CMFR1 induces SP70
accumulation. Antibody- and CMF-induced gene expression can be
inhibited by recombinant CMFR1 corresponding to the region between the
first and third potential transmembrane domains, indicating that this
region is extracellular and probably contains the CMF binding site.
These observations support a model where a one- or two-transmembrane
CMFR1 regulates gene expression and a G protein-coupled CMF receptor
mediates cAR1 signal transduction.
 |
INTRODUCTION |
Little is known about how specific cell types within a tissue
population are able to sense their cell density (see Refs. 1-4 for
review). The initiation of development in the simple eukaryote Dictyostelium discoideum provides a model system for this
type of cell density sensing. Dictyostelium normally live as
individual amoeboid cells that eat bacteria on soil surfaces (5,
6). The cells proliferate by fission and starve after overgrowing their
food source. Starving cells secrete a diffusible 80-kDa glycoprotein
called conditioned medium factor
(CMF)1 (7-12), and as the
number of starving cells in the population increases, the extracellular
concentration of CMF increases. When there is a high percentage of
starved cells, as indicated to the cells by a high concentration of
CMF, they aggregate using relayed pulses of cAMP as a chemoattractant.
The aggregated cells then form a fruiting body consisting of a mass of
spore cells supported by a thin stalk. Because CMF can diffuse into the
surrounding environment, the concentration of CMF is directly related
to the density of the cells secreting it (11). Considering starving cells as a subpopulation of the cells, CMF is thus a model for cell
density sensing (13).
Starved cells either at low cell densities or lacking CMF do not
aggregate, but they can be rescued by the addition of recombinant CMF,
suggesting that the function of CMF is to permit cAMP-mediated aggregation only when there is a high density of starving cells (9,
14). Pulses of cAMP are sensed by cAR1 receptors (15, 16), which
activate a heterotrimeric G protein complex, causing G 2 to release GDP and bind GTP (17-19).
Disassociated G then activates adenylyl cyclase, whereas
G 2-GTP induces an activation of guanylyl cyclase (15,
20-33). A cAMP-stimulated Ca2+ influx is mediated partly
by a G protein-dependent pathway and partly by a G
protein-independent pathway (34-36). Exposure of cells to CMF is
required for cAMP activation of both cyclases and Ca2+
influx (12).
CMF modulates cAMP signal transduction by regulating the lifetime of
the G 2-GTP conformation (12, 14, 37). GTP S partially inhibits the binding of CMF to membranes, suggesting that some of the
CMF signal transduction pathway involves a G protein-coupled receptor.
Cells lacking G 1 do not exhibit either GTP S inhibition of CMF
binding or CMF regulation of cAMP signal transduction, suggesting that
a putative CMF receptor interacts with G 1 (14). We have
found that CMF-induced G 1/ dissociation activates
phospholipase C, which in turn inhibits a G 2 GTPase,
thereby prolonging the cAMP-activated G 2-GTP
configuration and promoting the cAMP signal transduction process (14,
37).
In addition to regulating cAMP signal transduction, CMF is important
for the expression of early developmentally regulated genes including
prestalk and prespore genes (7-9, 38, 39). Expression of these genes
requires cells to be exposed to both CMF and cAMP and can occur in
cells lacking G 1, G 2, G , phospholipase C, or the cytosolic regulator of adenylyl cyclase (14). This suggested
that, unlike the regulation of phospholipase C by CMF, the induction of
prestalk and prespore gene expression by the combination of CMF and
cAMP is G protein-independent.
Scatchard plots of CMF binding to whole cells yielded a straight line,
indicating a single class of binding kinetics (10). To determine
whether there was one type of CMF receptor activating both the
G-dependent and G-independent CMF signal transduction pathways (40), we used affinity chromatography to isolate membrane proteins that bind CMF. We identified a 50-kDa protein, CMFR1, which is
sensitive to trypsin treatment of whole cells. We obtained partial
amino acid sequence of CMFR1 and isolated the cDNA encoding it. The
derived amino acid sequence has no significant similarity to any known
receptor, although there is some similarity to thiamine biosynthesis
enzymes and monooxygenases. CMFR1 has two or possibly three predicted
transmembrane domains. Expression of CMFR1 in insect cells caused an
increase in CMF binding, whereas disruption of cmfr1 in
Dictyostelium by homologous recombination resulted in the
loss of ~50% of CMF binding and all of its associated G-independent signal transduction. Although the cmfr1
cells do not aggregate, the G protein-dependent CMF signal
transduction pathway for IP3 was functional in
cmfr1 cells, suggesting that cells sense the
density-sensing factor CMF using two or more different receptors and
that CMFR1 regulates some unknown mechanism necessary for aggregation
(40). In this report, we identify and characterize distinct properties
of CMFR1 with respect to signal transduction and receptor membrane
topography and show that a likely reason cmfr1
cells do not aggregate is that CMFR1 regulates the expression of
adhesion proteins required for aggregation.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture--
Vegetative Dictyostelium Ax2
wild-type parental and cmfr1 cells were grown
in suspension shaking culture with HL-5, antibiotics, and vitamins as
described previously (41). To obtain starved cells, midlog phase cells
(2-5 × 106 cells/ml) were harvested by
centrifugation at 500 × g for 6 min, resuspended in
either PB (3 mM Na2HPO4, 7 mM KH2PO4, pH 6.5) or PBM (20 mM KH2PO4, 0.01 mM
CaCl2, 1 mM MgCl2, pH 6.1, with
KOH), collected by centrifugation again, and resuspended at 1-10 × 106 cells/ml at 21 °C. Cells were then shaken as for
growth conditions for 3-6 h. Conditioned starvation medium was made
following Brock and Gomer (41). Low cell density assays for CMF and
cAMP-induced expression of the SP70 marker were carried out using
immunofluorescence of 2500 cells/well seeded in eight-well slides as
described previously (42).
CMF and cAMP Binding--
CMF binding was measured as described
previously (10, 40). For cAMP binding, starved cells were washed three
times in cold PB and resuspended in this buffer to 2 × 107 cells/ml. The binding of [3H]cAMP was
then assayed in ammonium sulfate as described previously (43).
Expression of Recombinant CMF Active Site Fragments--
A PCR
was performed using the primers 5'-GCCATATGCGTCCACTCAATTGGAAA-3' and
5'-CGGGATCCTCAAGAAGTTATTGGAATGAG-3' using the Advantage 2 PCR kit
(CLONTECH, Palo Alto, CA) and
Dictyostelium genomic DNA as the template. A product from
519 to 780 bp of the CMF gene encoding the region from amino acid (aa)
101 to 188 (fragment 1, F1) was obtained (Fig. 1). Similar reactions
were performed to obtain fragments encoding aa 101-180 (F2), 120-188
(F3), 110-188 (F6), and 110-180 (F7). All of these DNA fragments
contained a NdeI site at the 5'-end and a BamHI
site at the 3'-end. The DNA fragments were digested and ligated into
the NdeI and BamHI sites of pET15b (Novagen,
Madison, WI). After confirming insert sequences (Lone Star
Laboratories, Inc., Houston, TX), the expression constructs were
transformed into Escherichia coli BL21(DE3)pLysS (Novagen), and recombinant protein was expressed following the Novagen prokaryotic expression instructions. The expressed CMF fragments were purified with
a B-PER His6 Spin Purification Kit (Pierce). To generate the shorter fragments F4 (aa 120-180), F5 (aa 120-170), F8 (aa 130-180), F9 (aa 130-170), F10 (aa 120-165), F11 (aa 120-159), and
F12 (aa 120-153), similar PCRs were done except that 5'
NdeI and 3' XhoI cloning sites were added, and
PCR products were digested and ligated into the expression/secretion
vector pET-22b (Novagen). CMF peptides were expressed in E. coli BL21(DE3)pLysS cells following the same protocol as above.
The growth medium containing the secreted proteins was clarified by
centrifugation, and 49.42 g of ammonium sulfate was added per 100 ml of
clarified growth medium at 0 °C. Precipitated CMF protein fragments
were collected by centrifugation at 20,000 × g for 15 min, resuspended in 20 mM Tris-HCl, pH 7.5, and then
purified using the B-PER His6 spin purification kit. Potential O-linked glycosylation sites were searched for
using the DictyOGlyc 1.1 server (available on the World Wide Web at www.cbs.dtu.dk/services/DictyOGlyc/) (44).
Expression of Recombinant CMFR1 Outer Loop Protein--
A YES
vegetative Dictyostelium cDNA library was obtained from
Dr. Eugeno De Hostos, and PCR was performed using Pfu
polymerase (Stratagene, La Jolla, CA) with the primers
5'-GGAATTCCATATGAGAGAAGGTAGAAAAGTTGC and
5'-CCGCTCGAGTTCGTGACCGAATTTAGCC containing the 5' NdeI and 3' XhoI cloning sites. A 999-bp DNA fragment was
gel-purified using GeneClean III (Qbiogene, Carlsbad, CA), ligated into
pET22b (Novagen), and cloned using the One Shot E. coli
transformation system (Invitrogen). The resulting C-terminal His tag
expression vector encoding aa 101-429 of CMFR1 was then used to
transform BL21-DE3 cells (Novagen), and the transformants were induced
in Terrific Broth containing 1 mM
isopropyl-1-thio- -D-galactopyranoside for 3 h at
37 °C (45). Cells were extracted with B-PER, and the 37.5-kDa
detergent-insoluble protein was solubilized in 8 M urea and
purified on a nickel column following the manufacturer's protocol
(Novagen). Urea was removed, and the protein was renatured by dialyzing
3 ml of protein in 500 ml of PBM with four changes over 48 h at
4 °C.
IP3, cAMP, and cGMP Production and Ca2+
Uptake--
The production of intracellular IP3 in
response to a 30-s pulse of CMF was determined following the procedure
of Van Haastert (46) using an IP3 3H assay
system (Amersham Biosciences) to quantitate IP3 with the exception that 100-µl aliquots of neutralized cell supernatants were
used. The production of cAMP in response to a pulse of the functional
analog 2'-deoxy-cAMP was determined following Van Haastert (46). Cells
starved at 107 cells/ml for 6 h were collected by
centrifugation and resuspended at 107 cells/ml. These were
stimulated with 10 µM 2'-deoxy-cAMP in the presence of 10 mM dithiothreitol. At 0, 3, and 5 min after stimulation, the cells were lysed, and cAMP was quantitated using an isotope dilution assay kit (Amersham Biosciences). The production of cGMP in
response to a 10-s pulse of 0.1 µM cAMP was determined in
a similar manner following the procedure of Kesbeke et al.
(47), using a cGMP assay kit (Amersham Biosciences). Cellular
Ca2+ uptake in response to a pulse of cAMP was determined
as described by Milne and Devreotes (48) with the following
modifications. Cells were starved for 6 h at a density of 5 × 106 cells/ml and were resuspended to a concentration of
107 cells/ml in HK buffer (20 mM Hepes, 5 mM KCl, pH 7.0). The cell suspension was incubated in
uptake buffer for 30 s, stimulated with a 10 µM
pulse of cAMP, and then incubated for an additional 40 s. The
cells were then collected by centrifugation at 1400 × g for 30 s and washed with 1 ml of ice-cold HK buffer
containing 10 mM Ca2+, and radioactivity was
measured by liquid scintillation counting.
Antibody Purification and Western Blots--
The generation of
antibodies 672 (Ab1) and 673 (Ab2) against the CMFR1 epitopes used for
Western blots and immunofluorescence has been described previously
(40). IgG was enriched from antiserum using ammonium sulfate (49) and
used for Western blots and immunofluorescence. The concentration of
total IgG in antibody preparations Ab1 (2 mg/ml) and Ab2 (3.5 mg/ml)
was determined by SDS-polyacrylamide gel electrophoresis comparing the
antibody preparation to a series of known concentrations of purified
rabbit IgG (R & D Systems, Inc., Minneapolis, MN). Fab fragments of
CMFR1 antibodies were generated and isolated from ammonium
sulfate-fractionated IgG using an ImmunoPure Fab Preparation Kit
(Pierce) following the manufacturer's directions. The concentration of
Fab fragments (0.4 mg/ml for both Ab1 and Ab2) was determined using the
Bio-Rad protein assay and purified rabbit IgG as a standard.
Immunofluorescence Microscopy--
Approximately 8 × 104 cells in 200 µl were placed in individual wells of an
eight-well glass slide and were allowed to attach for 1-6 h in HL5 or
PBM and then were fixed with 2% formalin, 0.2% glutaraldehyde, 0.02%
Triton X-100 in PBM for 5 min. Alternately, cells were fixed with 50%
ethanol, 10% formalin, 6.5% acetic acid, 0.4% picric acid for 20 min. Slides were washed in PBM followed by 15-min washes in 1 mg/ml
sodium borohydride at 4 °C and then PBS containing 0.1% SDS and
0.5% Nonidet P-40. Cells were then incubated for 1 h with Ab1 or
Ab2 at a 1:75 dilution in the PBS/SDS/Nonidet P-40 buffer, washed with
the same buffer for 30 min, and washed in PBS containing 0.05% Nonidet
P-40 for 10 min. Slides were then incubated with Alexa Fluor 488 goat
anti-rabbit antibody (Molecular Probes, Inc., Eugene, OR) at a 1:300
dilution in PBS-N for 45 min. Following two 30-min washes, the slides
were mounted as previously described (42). Cells were examined with a
Nikon Microphot Fx with a 1.4 NA 60× lens, a Deltavision (Applied
Precision, Issaquah, WA) deconvolution microscope with a Zeiss 1.4 NA
100× lens, or a Zeiss LSM-410 confocal microscope.
RNA Analysis--
RNA was isolated from 5 × 107 cells either at the vegetative stage or at various
times during starvation in shaking culture with or without pulses of
cAMP, essentially as previously described (40), using the RNeasy mini
kit (Qiagen Inc., Valencia, CA). Electrophoresis of RNA (10 µg/lane)
and transfer to Duralon UV membrane (Stratagene) were done following
the manufacturer's directions. Equal loading was verified by ethidium
bromide staining of rRNA in the gels. The cDNA probes for cAR1
(15), gp80 (50), discoidin (51), and phosphodiesterase (PDE) (52) were
labeled with [32P]dCTP by random hexamer-primed DNA
synthesis (Amersham Biosciences) and hybridized with the blots in a
60 °C reaction containing 0.25 M
Na2HPO4, 0.25 M NaCl, 0.5% SDS, 1 mM EDTA, 10% polyethylene glycol
(Mr 8000), pH 7.2. Blots were then washed with
50 mM Na2HPO4, 0.5% SDS, pH 7.2, for 30 min at 25 °C and 15 min at 60 °C. Autoradiography on
preflashed Kodak X-Omat AR5 film was done at 70 °C.
SP70 Expression in Response to Glutathione
S-Transferase-CMF-Sepharose--
Approximately 104
glutathione-Sepharose 4B beads (Amersham Biosciences) were incubated
with 1.6 µg of recombinant glutathione S-transferase-CMF,
prepared as described (10), for 30 min at 4 °C in 0.2 ml of PBS. The
beads were then washed five times with 1-ml volumes of PBS, two times
with PBM, and finally resuspended in 0.2 ml of PBM. To assay SP70
expression, Ax2 cells were starved in eight-well glass slides at 10, 7.5, and 5 × 103 cells per well, and after 6 h,
either ~1500, ~1000, or ~500 glutathione S-transferase-CMF-Sepharose beads were added to the wells
together with cAMP (300 µM). Cells were fixed and stained
for SP70 12 h later, and positive cells were scored as described above.
 |
RESULTS |
Overlapping but Distinct Regions of CMF Activate the Two CMF
Pathways--
CMF stimulates both G protein-dependent and
-independent signal transduction pathways (14). We previously
identified a putative receptor for CMF, CMFR1, which is necessary for
CMF-stimulation of G protein-independent prestalk and prespore gene
expression but not G protein-dependent IP3
production (40). This suggested, but did not prove, that there are two
receptors for CMF. To test the hypothesis that there are two separate
receptors for CMF, we first determined whether a difference could be
detected between the two receptors with respect to CMF binding
affinities by measuring the KD for
125I-labeled CMF binding to parental and
cmfr1 cells. As shown in Table
I, there was no detectable difference in
the KD between the two cell types. The
KD for both cell types was what we previously
observed for wild-type cells (10, 40), whereas the number of CMF
receptors for Ax2 cells was considerably less than that reported for
Ax4. This sort of difference also occurs for cAMP receptors, with Ax2
cells having considerably less cAMP binding than
Ax4.2 As previously observed
(40), there are about half the number of CMF receptors on
cmfr1 cells compared with parental cells. The
similar KD for CMF binding to parental and
cmfr1 cells suggests that the G
protein-coupled receptor (the only expected CMF receptor in
cmfr1 cells) has the same
KD as the mixture of CMFR1 and this receptor, so by
this criterion we cannot demonstrate the existence of two different
receptors.
View this table:
[in this window]
[in a new window]
|
Table I
Binding of CMF to cells
Ax2 and cmfr1 cells were starved for 6 h in
shaking culture at 5 × 106 cells/ml. The cells were
harvested, and the binding of 125I-labeled CMF was measured.
Data are means ± S.D.
|
|
We then determined whether differences in the two receptors could be
detected with respect to the region of CMF that activates the receptor.
Twelve different recombinant peptide fragments of the CMF active site
were generated and examined for their ability to stimulate SP70 (a
protein expressed in a subset of prespore cells) accumulation and
IP3 production. As shown in Fig.
1, a fragment encoding amino acids
120-180 of CMF (fragment 4) had essentially full activity for
stimulating both pathways. We previously found that the
EC50 of purified or recombinant CMF is ~300 pg/ml (8, 9).
The EC50 of fragment 4 is considerably lower (indicating a
much higher specific activity). This is in agreement with our observation that small breakdown fragments of CMF have a much higher
specific activity than the entire protein (53). Deletion of amino acids
171-180 (creating fragment 5) resulted in almost complete loss of
fragment-stimulated IP3 production with little effect on
SP70 accumulation. Further deletion of amino acids 166-170 (fragment
10) abolished the ability of the CMF fragment to stimulate SP70
accumulation. No significant decrease in either IP3
production or SP70 accumulation occurred by deleting amino acids
101-120 with the C terminus fixed at 180 or 188 (Fig. 1). However,
deleting only amino acids 101-109 decreased SP70 accumulation,
indicating that having just amino acids 110-129 rather than 101-129
or 120-129 interferes with the CMF active site. Deletion of amino
acids 120-129 to create fragment 8 resulted in a significant decrease
in both IP3 and SP70 expression (Fig. 1). Thus, the
essential stimulatory ability of the CMF resides in amino acids
120-180, with amino acids 171-180 being more crucial for activating
the IP3 pathway, 166-170 being necessary for gene
expression, and 120-129 being necessary for both pathways. The
differential capacities of the various CMF fragments strongly suggest
that distinct regions within the CMF active site operate on two
different receptors and pathways.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
There are differences in the recombinant CMF
active sites stimulating G protein-dependent and
-independent pathways. IP3 levels were measured in Ax2
cells with and without a 30-s stimulation with 0.3 ng/ml of the various
recombinant CMF active site fragments. For each experiment, the
percentage increase caused by the CMF fragment is shown. To assay gene
expression, cells were starved at low cell density in monolayer culture
on glass slides in the presence of a series of dilutions of the
recombinant CMF fragments. Six hours after starvation, cAMP was added
to 300 µM, and the cells were fixed and stained for SP70
12 h later. Values are means ± S.E. from at least three
separate experiments of the lowest concentration of the fragment that
caused at least 25% of the cells to express SP70. ND, not
determined; none, no activity was detected at any
concentration.
|
|
Role of CMFR1 in cAMP-mediated Signal Transduction--
We
previously found that CMF regulates cAMP signal transduction via a
pathway involving an unknown G protein-coupled CMF receptor, G 1, and
phospholipase C (14). These studies could not exclude the possibility
that a G protein-independent CMF signal transduction pathway also
regulates cAMP signal transduction. We therefore examined whether
second messenger pathways, which are activated by cAMP and its G
protein-coupled receptor cAR1, are altered in cmfr1 cells. Cells were starved for 5 h
at low cell density (106 cells/ml) prior to signal
transduction assays to prevent cAMP accumulation, pulsing, and
up-regulation of cAR1. This basal starvation condition was also
relevant in that assays for cAMP induction of SP70 gene expression are
done at low cell density. Table II shows
that both wild type Ax2 and cmfr1 cells bound
similar amounts of cAMP under basal conditions. However, a dramatic
difference was observed after 5 h of pulsing with cAMP. A nearly
7-fold increase in binding was seen with wild-type cells, whereas
little change was found for cmfr1 cells. This
indicates that while CMFR1 may not be necessary for basal levels of
cAR1, it is involved in the mechanism for cAMP-pulse-induced up-regulation of cAR1.
View this table:
[in this window]
[in a new window]
|
Table II
The binding of [3H]cAMP to Ax2 and cmfr1
cells
Cells were starved for 5 h in shaking culture at 106
cells/ml with and without 40 µM cAMP pulses at 6-min
intervals. The cells were harvested and extensively washed, and the
binding of [3H]cAMP in the presence of ammonium sulfate,
which tends to equalize the affinity of all the different forms of cAR1
(68), was measured. Values are the means ± S.E. of at least three
independent experiments; the ratio of the cAMP pulsed value to no cAMP
pulse value was calculated separately for each experiment, and the
mean ± S.E. is shown as -fold increase. The differences in -fold
increases between the two cell lines is significant at
p < 0.005.
|
|
When wild-type and cmfr1 cells were stimulated
with 10 µM 2'-deoxy-cAMP for 3 and 5 min, an ~2-fold
increase was observed in cAMP production (Table
III). Similarly, as shown in Table
IV, stimulation of wild-type and mutant
cells with 0.1 µM cAMP for 10 s resulted in
~2-fold increases in cGMP levels. In both cell types, there also
appeared to be no significant difference in basal levels of cAMP or
cGMP. This suggests that CMFR1 does not regulate cAMP-stimulated cAMP
or cGMP accumulation.
View this table:
[in this window]
[in a new window]
|
Table III
Production of cAMP in response to cAMP stimulation in Ax2 and
cmfr1 cells
Cells were starved for 5 h, harvested, extensively washed, and
resuspended in PB. For each experiment, cAMP production was measured in
duplicate at 0, 3, and 5 min after stimulation with 2' -deoxy-cAMP.
Values are the means ± S.E. from at least three separate
experiments; the ratio of the average of the 3- and 5-min values to the
0-min value was calculated separately for each experiment, and the
mean ± S.E. is shown as the -fold increase. The -fold increases
are not significantly different at p > 0.4.
|
|
View this table:
[in this window]
[in a new window]
|
Table IV
Production of cGMP in response to cAMP stimulation in Ax2 and
cmfr1 cells.
Cells were starved for 5 h, harvested, washed, and resuspended in
PB. For each experiment, cGMP production was measured in duplicate at 0 and 10 s after stimulation with cAMP. The values are the
means ± S.E. from six separate experiments; the ratio of the 10-s
value to the 0-s value was calculated separately for each experiment,
and the mean ± S.E. is shown as the -fold increase. The -fold
increases are not significantly different at p > 0.45.
|
|
A pulse of cAMP also causes a transient Ca2+ influx in
starved Dictyostelium cells (48, 54). Basal Ca2+
influx was similar in Ax2 and cmfr1 , and
whereas relatively little cAMP-stimulated Ca2+ influx was
observed for cmfr1 , it was not significantly
different compared with the 25% increase seen for wild-type cells
(Table V). cAR1 levels have been shown to
be directly proportional to the extent of cAMP-induced Ca2+
influx (48, 54). When Ax2 cells were pulsed with cAMP, a nearly 3-fold
increase in cAMP-stimulated Ca2+ influx was observed,
whereas cmfr1 cells showed no significant
cAMP-stimulated Ca2+ influx (Table V). This lack of
response is consistent with the inability of
cmfr1 to up-regulate cAR1 (Table II) and
indicates that, for unknown reasons, pulsing
cmfr1 cells with cAMP abrogates their
cAMP-stimulated Ca2+ influx. Together, the data indicate
that CMFR1 is required for some but not all of the cAMP-stimulated
Ca2+ influx.
View this table:
[in this window]
[in a new window]
|
Table V
45Ca2+ uptake by Ax2 and cmfr1 cells in
response to cAMP stimulation
Cells were starved for 6 h at a density of 5 × 106
cells/ml without or with pulses of cAMP every 6 min. The cells were
then harvested, extensively washed, and incubated in uptake buffer for
30 s followed by an additional 40-s incubation either without or with
10 µM cAMP. The amount of 45Ca2+ taken up
by cells was determined in duplicate, and the values are the means ± S.E. from at least three separate experiments. The ratio of the
cAMP-stimulated value to no cAMP value was calculated separately for
each experiment, and the mean ± S.E. is shown as -fold increase.
A paired t test indicated that the -fold increase in
Ca2+ uptake is not significantly different between unpulsed Ax2
cells and unpulsed cmfr1 cells at
p = 0.25.
|
|
CMFR1 Regulates Gene Expression at the Level of mRNA
Accumulation--
CMF regulates the expression of early genes such as
discoidin I and cAR1 as well as prestalk and
prespore genes (7, 8, 12). We previously found that CMFR1 mediates the
CMF induction of prestalk and prespore protein expression (40). To
determine whether CMFR1 mediates the CMF regulation of discoidin
I and cAR1, we examined their expression in
cmfr1 cells. After 3 h of starvation,
cAR1 mRNA levels in cmfr1 were
approximately half that observed for wild-type cells, and although
there was a slight increase after 6 h of pulses, cAR1 mRNA levels were significantly less in
cmfr1 versus wild-type (Fig.
2). The role for CMFR1 in the
non-pulse-induced discoidin I gene as well as that for the
pulse-induced gp80 gene is even more dramatic, since
essentially no detectable messages were observed. This impaired
expression was confirmed in cmfr1 cells by
immunofluorescence and Western blots, which also showed significant
attenuation of levels of the adhesion protein gp24 (data not shown).
The absence of CMFR1 has a more complex effect on phosphodiesterase
mRNA, although normal levels of the vegetative species were seen in
cmfr1 . Whereas normal levels of the
developmental species were also observed at 3 h, it was
pulse-down-regulated in contrast to wild-type; after 6 h, the
levels were significantly reduced unless the cells were pulsed. All
levels of the developmental species were significantly less than
wild-type except for 3 h without pulsing. It therefore appears
that CMFR1 regulates the expression of a variety of genes expressed
during early development.

View larger version (98K):
[in this window]
[in a new window]
|
Fig. 2.
Early gene expression is decreased in
cmfr1 cells. Total RNA (10 µg)
prepared from wild-type (WT) Ax2 (left
panels) and cmfr1 (right
panels) cells at the vegetative stage (v), and 3- and 6-h intervals of starvation with or without cAMP pulses
(p), was resolved by 1.2% agarose/formaldehyde gel
electrophoresis and blotted to nylon membranes. Blots were probed using
cAR1, discoidin, gp80, or PDE cDNA fragments. The gel was stained
with ethidium bromide to verify that equal amounts of rRNA were present
in each lane of samples.
|
|
CMFR1 Is a Transmembrane Protein with an Extracellular
Domain--
We wanted to determine whether antibody binding could
mimic CMF-mediated stimulation of prespore gene expression, which could subsequently also help define the membrane topography of CMFR1. A
similar strategy using a Myc-tagged protein has been reported for the
Dictyostelium transmembrane histidine kinase, DhkA (55). Thus, antibody Ab1 was raised against an amino acid sequence of CMFR1
that resides between the first potential transmembrane domain and the
second potential transmembrane domain, whereas Ab2 was raised against a
region between the latter domain and the third potential transmembrane
domain. When cells were incubated with either Ab1 or Ab2, SP70
accumulation was induced over a range of dilutions, whereas the
respective preimmune preparations were ineffective (Table
VI). Whereas the dilution profile of
stimulation was similar for both antibodies, Ab1 induced a higher
overall degree of expression. Since both antibodies were stimulatory
when applied extracellularly, it would appear that both of their
binding sites are extracellular, and thus the second possible
transmembrane domain is not a true transmembrane domain.
View this table:
[in this window]
[in a new window]
|
Table VI
Antibodies against CMFR1 induce SP70 accumulation
Ax2 cells were starved at low cell density in monolayer culture on
glass slides in the presence of various dilutions of anti-CMFR1 Ab1,
Ab2, or preimmune antibodies. Six hours after starvation, cAMP was
added, and SP70 accumulation was assayed 12 h later. , less than
1% of the cells expressing the marker; +/ , 1-25% of the cells
expressing the marker; +, 25-45% of the cells expressing the marker.
Identical results were obtained in three separate experiments. For a
positive reference, the complete recombinant CMF protein was used at 1 ng/ml and scored +; no SP70 expression was seen when cAMP was not
added.
|
|
To determine whether antibody activation of CMFR1 occurs through the
receptor dimerizing by the divalent IgG binding or direct stimulation
of the receptor, Fab fragments (which have a single antigen binding
site) were prepared. An even greater degree of SP70 accumulation was
observed for both Fab1 and Fab2 compared with the IgG (Table
VII). The efficacy of Fab-induced SP70
accumulation indicates that monovalent binding to either CMFR1 antigen
site can substitute for CMF-mediated stimulation. We also found that when CMF was bound to beads 5-17-fold larger than
Dictyostelium cells, the CMF activated SP70 accumulation
(data not shown). Together, the data strongly suggest that CMF does not
need to be internalized to activate CMFR1 and that the Ab1-binding and
the Ab2-binding domains of CMFR1 are both extracellular.
View this table:
[in this window]
[in a new window]
|
Table VII
Inhibition of Fab-induced SP70 accumulation by recombinant CMFR1
Fab fragments prepared from Ab1 and Ab2 IgG digests were preincubated
with or without recombinant CMFR1 at a 1:3 molar ratio for 40 min at
21° C. Ax2 cells were then starved at low cell density in multiwell
slides in the presence of various dilutions of the Fab/rCMFR1 mixture
and assayed for SP70 accumulation as described in Table VI. The assay
results were identical in three separate experiments. For a positive
reference, recombinant CMF at 1 ng/ml was used and scored +.
|
|
To further test the hypothesis that the regions of CMFR1 that are
recognized by Ab1 and Ab2 are extracellular, a recombinant protein
containing the sequence between the first and the third potential
transmembrane domains was generated. Since this protein contains the
binding sites for Ab1 and Ab2 as well as the possible CMF binding site,
it should competitively inhibit both antibody- and CMF-induced gene
expression. As shown in Table VII, when cells were incubated with Fab1
or Fab2 that previously was incubated for 40 min with recombinant outer
loop protein at a 1:3 molar ratio, a significant reduction in
Fab-induced SP70 accumulation was observed.
Similarly, CMF-induced SP70 accumulation
was negatively affected by the presence of outer loop protein (Table
VIII). At a 1:100 molar ratio of CMF to outer loop, SP70 accumulation
was not observed, and it was reduced by 50% at a 1:1 ratio; complete CMF induction did occur, however, at a 1:0.1 ratio or less (Table VIII). The ability of the CMFR1 outer loop protein to inhibit both antibody- and CMF-induced SP70 accumulation supports a one- or two-span
transmembrane model for CMFR1 and strongly suggests that the
extracellular CMF binding site resides between the first and third
potential transmembrane domains.
View this table:
[in this window]
[in a new window]
|
Table VIII
Inhibition of CMF-induced SP70 accumulation by recombinant CMFR1
Recombinant CMF (1.5 ng/ml) was preincubated with recombinant CMFR1 at
the indicated molar ratios for 40 min at 21° C. Ax2 cells were
then starved at low cell density in multiwell slides in the
presence of the CMF/CMFR1 mixtures. SP70 accumulation was assayed
as described in Table VI. The assay results were identical in
three separate experiments.
|
|
Cellular Localization of CMFR1--
To further examine the
cellular localization of CMFR1, wild-type and
cmfr1 cells were stained with anti-CMFR1
antibodies using immunofluorescence. As shown in Fig.
3A, there was staining of Ax2
cells, whereas no staining was observed in
cmfr1 cells (Fig. 3B). When we
examined the staining pattern more closely using deconvolution
microscopy, the fluorescence was associated with the periphery of
cells, with some punctile staining in the interior of cells (Fig.
3C). There was no discernible difference in the staining
observed with Ab1 versus Ab2 (data not shown).

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 3.
Subcellular localization of CMFR1. Cells
were starved in shaking culture for 5 h and then allowed to
adhere to glass slides. The cells were fixed and stained for CMFR1 by
immunofluorescence. Parental (A) and
cmfr1 cells (B) were stained, and
fluorescence was observed with a conventional fluorescence microscope.
WT, wild type; bar, 10 µm. C,
wild-type cells as shown in A were imaged using a
deconvolution microscope. Bar, 5 µm.
|
|
 |
DISCUSSION |
One Ligand Activates Two Different Receptors--
We previously
observed that disrupting cmfr1 abolishes some but not all
aspects of CMF signal transduction, suggesting that there are two
different CMF receptors. In this report, we show that there is a
difference in the domains of CMF needed to activate the
G 1-mediated and the CMFR1-mediated CMF signal
transduction pathways. This strongly supports the hypothesis that there
are indeed two different receptors for CMF. Although there exist
nonfunctional decoy receptors that bind ligands such as Fas ligand and
interleukin-1 (56, 57), there are very few known examples of one ligand activating two different functional receptors on a cell. These include
two distinct domains of thrombin activating different pathways and
cellular responses through separate receptors on fibroblasts (58) and
the CD80 and CD86 ligands both activating CD28 and CTLA-4 receptors on
T cells (59).
We previously found that the CMF active site lies within an 88-amino
acid region of the 570-amino acid CMF polypeptide backbone (10). We
found here that the active site can be narrowed to 60 amino
acids (amino acids 120-180) with a predicted mass of 6532 Da. We
previously found that cleavage of sites between 120 and 180 with
trypsin (53), chymotrypsin, and cyanogen
bromide3 destroys CMF
activity. Furthermore, a series of ~30-mer peptides beginning at aa
101, 115, 130, 145, and 160 showed no CMF
activity,4 suggesting that
the active site of CMF spans the entire 60 aa between 120 and 180. Our
delineation of the CMF active site stimulating CMFR1 and the receptor
activating the G 1 pathway indicates that both receptors
are activated by essentially the same region of CMF.
Assuming that there are only two types of CMF receptors, the
observation that the KD for CMF binding to
cmfr1 cells is 2.1 nM (Table I)
suggests that this is the KD of the G
protein-coupled CMF receptor. We observed that wild-type cells have
approximately twice the number of binding sites for CMF compared with
cmfr1 cells, suggesting that the increased
amount of binding is due to the presence of CMFR1. Since Scatchard
plots showed an apparent single class of CMF binding sites on cells
(10), this suggests that CMF binds to CMFR1 with a
KD of 2.1 nM. This then implies that at
any given CMF concentration both CMF receptors have roughly the same
percentage of occupancy. We have observed that for both the
CMF-stimulated production of IP3 and accumulation of SP70
and CP2, the maximal stimulation occurs at roughly 1 ng/ml (13 pM) CMF (10, 14). Ax4 cells contain roughly 40,000 CMF receptors (10). However, we find that Ax2 cells appear to have only
about 660 CMF receptors per cell. It is unclear why there is such a
large difference between the number of receptors per Ax2 and Ax4 cells.
CMFR1 and G Protein-independent Signal
Transduction--
cAR1-activated G 2-GTP and G stimulate cGMP
and cAMP production, respectively (60). CMF regulates cAMP and cGMP
production by regulating the lifetime of the cAR1-activated
G 2-GTP via G 1, G , and phospholipase C (10-12, 14,
37, 40). CMFR1 is not required for cAR1 activation of cAMP and cGMP
accumulation under conditions where cAR1 levels are not up-regulated by
pulses of cAMP (Tables III and IV). Although we find that CMFR1 plays
an important role in cAMP-induced pulse up-regulation of cAMP binding (Table II) and gene expression (Fig. 2), CMFR1 does not appear to
regulate any pathway downstream of cAR1.
Cells lacking CMF also do not exhibit cAMP-stimulated Ca2+
uptake but the response can be rescued by a 10-s exposure of these cells to CMF (12). Although the cAMP-stimulated Ca2+ uptake
has been reported to be independent of G subunits 1, 2, 3, 4, 7, or
8 and the G subunit (48) and is directly proportional to cAR1 levels
(48, 54), Ca2+ influx has also been found to be reduced by
50-70% in G 2- and G -negative strains (35). Since
the G protein-coupled CMF receptor seems to function by activating
G 1 and G (14), this receptor could be involved with
cAMP-stimulated Ca2+ uptake. There is evidence that CMF
could affect Ca2+ uptake via fast and slow pathways. CMF
rapidly affects the cAMP binding site kinetics of cAR1 (43) and can
also down-regulate cAMP binding both in wild-type and in
cmfr1 cells (40, 43). Thus, simply the binding
of CMF to its G protein-coupled receptor could rapidly cause a
permissive conformation of cAR1 for Ca2+ uptake. CMF could
also affect cAMP-stimulated Ca2+ uptake more slowly via
CMFR1, since decreased levels of cAR1 mRNA observed in
cmfr1 cells (Fig. 2) correlate with the lack
of cAMP pulse-induced increases in cAMP binding (Table II).
CMFR1 appears to play an important role in the regulation of several
genes involved in the growth differentiation transition, including
those for the cell surface adhesion proteins gp24 and gp80. Indeed, the
most dramatic characteristic of cells lacking CMFR1 is the
aggregation-minus phenotype. Whereas gp24 is involved with the initial
formation of filopodia-mediated intercellular contacts and aggregation,
gp80 plays a later role in cellular streaming (61). Antibodies against
gp24 (62) and gp80 (63) block aggregation or cause abnormal streaming,
thereby arresting further development. Thus, the inability of
cmfr1 cells to aggregate into
mounds and streams can be explained by significant impairment in the
expression of these genes (Fig. 2). In contrast to almost undetectable
gp80 and discoidin messages, expression of both cAR1 and PDE genes is
somewhat attenuated (Fig. 2). Aside from pathways such as
Ca2+ influx, which is directly proportional to cAR1 levels,
there do not appear to be significant effects of reduced cAR1 and PDE levels, since the cAMP-mediated signal transduction pathways examined appear normal, and pulses of cAMP can still down- and up-regulate PDE
messages at 3 and 6 h of starvation, respectively. In addition, it
is unlikely that CMFR1 affects expression of CMF, since the levels of
CMF secreted by cmfr1 cells are ~75% of
those observed for Ax2 wild-type
cells.5
Membrane Association and Topology of CMFR1--
Immunofluorescence
showing that some CMFR1 is near the periphery of the cell, combined
with the observation that when CMF is attached to beads that are much
larger than the cell this bead-CMF complex can stimulate
CMFR1-activated gene expression, suggests that some CMFR1 is on the
plasma membrane. An examination of the predicted amino acid sequence of
CMFR1 indicated that there were three potential transmembrane (PTM)
domains (40). Our observation that antibodies directed against a domain
between PTM1 and PTM2 when added to live cells induce SP70 expression
suggests that this region is extracellular. Similarly, the ability of
antibodies against a domain between PTM2 and PTM3 to induce SP70
expression indicates that this region is also extracellular. This then
implies that the potential TM2 is not a TM region and suggests that TM1 and/or TM3 are true TM domains. The ability of the Fab fragments of the
antibodies to stimulate SP70 expression (Table VII) suggests that the
antibodies were directly stimulating the receptor rather than
artificially causing receptors to dimerize. CMFR1 could be a one-span
type I receptor such as the bacterial chemotaxis receptor for
aspartate, the human growth hormone receptor, or the human asialoglycoprotein receptor (64, 65). However, topology with TM1 as the
single TM domain would leave only the ~23 N-terminal amino acids of
CMFR1 in the cytosol; if a single TM region was TM3 there would be the
~60 C-terminal amino acids in the cytosol. On the other hand, if
CMFR1 is a two-span receptor with both the N and C termini inside the
cell, it would have a topography similar to bacterial and
Dictyostelium histidine kinase receptors (55, 66, 67).
In summary, the antibody- and bead-coupled CMF stimulations as well as
immunofluorescence observations suggest that some CMFR1 is located on
the extracellular side of the plasma membrane, consistent with it being
a receptor. The lack of CMFR1 does not affect CMF-mediated cAMP-stimulated cAMP or cGMP production, but it does affect
cAMP-regulated gene expression. Taken together with the observation
that different domains of CMF activate the G
protein-dependent and G protein-independent CMF pathways,
it appears that CMFR1 is one of at least two different receptors for
the cell density-sensing factor CMF.
 |
ACKNOWLEDGEMENTS |
We thank Darrell Pilling and Karen Ehrenman
for advice and Diane Hatton for assistance with the manuscript.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
An Investigator of the Howard Hughes Medical Institute. To whom
correspondence should be addressed: Howard Hughes Medical Institute,
Dept. of Biochemistry and Cell Biology, MS-140, Rice University, 6100 S. Main St., Houston, TX 77005-1892. Tel.: 713-348-4872; Fax:
713-348-5154; E-mail: richard@rice.edu.
Published, JBC Papers in Press, June 17, 2002, DOI 10.1074/jbc.M204539200
2
L. Tang and R. H. Gomer, unpublished results.
3
N. Ghbeish and R. H. Gomer,
unpublished observations.
4
R. Ammann and R. H. Gomer, unpublished observations.
5
W. J. Deery, T. Gao, R. Ammann, and
R. H. Gomer, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
CMF, conditioned
medium factor;
aa, amino acid(s);
F1-F11, fragments 1-11,
respectively;
IP3, inositol 1,4,5-trisphosphate;
PBS, phosphate-buffered saline;
PDE, phosphodiesterase;
PTM, potential
transmembrane;
TM, transmembrane.
 |
REFERENCES |
| 1.
|
Clarke, M.,
and Gomer, R. H.
(1995)
Experientia
51,
1124-1134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Jequier, E.,
and Tappy, L.
(1999)
Physiol. Rev.
79,
451-480[Abstract/Free Full Text]
|
| 3.
|
Elmquist, J.,
Elias, C.,
and Saper, C.
(1999)
Neuron
22,
221-232[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Gomer, R. H.
(2001)
Nat. Rev.
2,
48-54[CrossRef]
|
| 5.
|
Loomis, W. F.
(1975)
Dictyostelium discoideum: A Developmental System
, Academic Press, New York
|
| 6.
|
Maeda, Y.
(1997)
in
Dictyostelium: A Model System for Cell and Developmental Biology
(Maeda, Y.
, Inouye, K.
, and Takeuchi, I., eds)
, pp. 207-218, Universal Academy Press, Tokyo, Japan
|
| 7.
|
Mehdy, M. C.,
and Firtel, R. A.
(1985)
Mol. Cell. Biol.
5,
705-713[Abstract/Free Full Text]
|
| 8.
|
Gomer, R. H.,
Yuen, I. S.,
and Firtel, R. A.
(1991)
Development
112,
269-278[Abstract]
|
| 9.
|
Jain, R.,
Yuen, I. S.,
Taphouse, C. R.,
and Gomer, R. H.
(1992)
Genes Dev.
6,
390-400[Abstract/Free Full Text]
|
| 10.
|
Jain, R.,
and Gomer, R. H.
(1994)
J. Biol. Chem.
269,
9128-9136[Abstract/Free Full Text]
|
| 11.
|
Yuen, I. S.,
and Gomer, R. H.
(1994)
J. Theor. Biol.
167,
273-282[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Yuen, I. S.,
Jain, R.,
Bishop, J. D.,
Lindsey, D. F.,
Deery, W. J.,
Van Haastert, P. J. M.,
and Gomer, R. H.
(1995)
J. Cell Biol.
129,
1251-1262[Abstract/Free Full Text]
|
| 13.
|
Gomer, R. H.
(1994)
Curr. Biol.
4,
734-735[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Brazill, D. T.,
Lindsey, D. F.,
Bishop, J. D.,
and Gomer, R. H.
(1998)
J. Biol. Chem.
273,
8161-8168[Abstract/Free Full Text]
|
| 15.
|
Klein, P. S.,
Sun, T. J.,
Saxe III, C. L.,
Kimmel, A. R.,
Johnson, R. L.,
and Devreotes, P. N.
(1988)
Science
241,
1467-1472[Abstract/Free Full Text]
|
| 16.
|
Saxe, S. A.,
and Kimmel, A. R.
(1988)
Dev. Genet.
9,
259-266[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Van Haastert, P. J. M.
(1984)
Biochem. Biophys. Res. Commun.
124,
597-604[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Theibert, A.,
and Devreotes, P.
(1986)
J. Biol. Chem.
261,
15121-15125[Abstract/Free Full Text]
|
| 19.
|
Van Haastert, P. J. M.,
Snaar-Jagalska, B. E.,
and Janssens, P. M. W.
(1987)
Eur. J. Biochem.
162,
251-258[Medline]
[Order article via Infotrieve]
|
| 20.
|
Kumagai, A.,
Pupillo, M.,
Gundersen, R.,
Miake-Lye, R.,
Devreotes, P. N.,
and Firtel, R. A.
(1989)
Cell
57,
265-275[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Peters, D. J. M.,
Cammans, M.,
Smit, S.,
Spek, W.,
Campagne, M. M. V.,
and Schaap, P.
(1991)
Dev. Genet.
12,
25-34[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Pitt, G. S.,
Milona, N.,
Borleis, J.,
Lin, K. C.,
Reed, R. R.,
and Devreotes, P. N.
(1992)
Cell
69,
305-315[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Lilly, P., Wu, L. J.,
Welker, D. L.,
and Devreotes, P. N.
(1993)
Genes Dev.
7,
986-995[Abstract/Free Full Text]
|
| 24.
|
Firtel, R. A.
(1995)
Genes Dev.
9,
1427-1444[Free Full Text]
|
| 25.
|
Wu, L.,
Hansen, D.,
Franke, J.,
Kessin, R. H.,
and Podgorski, G. J.
(1995)
Dev. Biol.
171,
149-158[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Chen, M.,
Insall, R.,
and Devreotes, P.
(1996)
Trends Genet.
12,
52-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Van Haastert, P. J. M.,
and Kuwayama, H.
(1997)
FEBS Lett.
410,
25-28[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Parent, C. A.,
Blacklock, B. J.,
Froehlich, W. M.,
Murphy, D. B.,
and Devreotes, P. N.
(1998)
Cell
95,
81-91[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Meili, R.,
Ellsworth, C.,
Lee, S.,
Reddy, T. B., Ma, H.,
and Firtel, R. A.
(1999)
EMBO J.
18,
2092-2105[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Wang, B.,
Shaulsky, G.,
and Kuspa, A.
(1999)
Dev. Biol.
208,
1-13[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Firtel, R. A.,
and Meili, R.
(2000)
Curr. Opin. Genet. Dev.
10,
421-427[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Jin, T.,
Zhang, N.,
Long, Y.,
Parent, C. A.,
and Devreotes, P. N.
(2000)
Science
287,
1034-1036[Abstract/Free Full Text]
|
| 33.
|
Chung, C. Y.,
Funamoto, S.,
and Firtel, R. A.
(2001)
Trends. Biochem. Sci.
26,
557-566[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Milne, J. L., Wu, L.,
Caterina, M. J.,
and Devreotes, P. N.
(1995)
J. Biol. Chem.
270,
5926-5931[Abstract/Free Full Text]
|
| 35.
|
Schaloske, R.,
and Malchow, D.
(1997)
Biochem. J.
327,
233-238[Medline]
[Order article via Infotrieve]
|
| 36.
|
Sonnemann, J.,
Aichem, A.,
and Schlatterer, C.
(1998)
FEBS Lett.
436,
271-276[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Brazill, D. T.,
Gundersen, R.,
and Gomer, R. H.
(1997)
FEBS Lett.
404,
100-104[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Mann, S. K.,
and Firtel, R. A.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
1924-1928[Abstract/Free Full Text]
|
| 39.
|
Secko, D.,
Khosla, M.,
Gaudet, P.,
Tsang, A.,
Spiegelman, G.,
and Weeks, G.
(2001)
Exp. Cell Res.
266,
135-141[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Deery, W. J.,
and Gomer, R. H.
(1999)
J. Biol. Chem.
274,
34476-34482[Abstract/Free Full Text]
|
| 41.
|
Brock, D. A.,
and Gomer, R. H.
(1999)
Genes Dev.
13,
1960-1969[Abstract/Free Full Text]
|
| 42.
|
Gomer, R. H.
(1987)
in
Methods in Cell Biology
(Spudich, J. A., ed)
, pp. 471-487, Academic Press, Inc., Orlando, FL
|
| 43.
|
Van Haastert, P. J. M.,
Bishop, J. D.,
and Gomer, R. H.
(1996)
J. Cell Biol.
134,
1543-1549[Abstract/Free Full Text]
|
| 44.
|
Gupta, R.,
Jung, E.,
Gooley, A. A.,
Williams, K. L.,
Brunak, S.,
and Hansen, J.
(1999)
Glycobiology
9,
1009-1022[Abstract/Free Full Text]
|
| 45.
|
Pan, S.,
and Malcolm, B.
(2000)
BioTechniques
29,
1234-1238[Medline]
[Order article via Infotrieve]
|
| 46.
|
Van Haastert, P. J. M.
(1989)
Anal. Biochem.
177,
115-119[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Kesbeke, F.,
Snaar-Jagalska, B. E.,
and Van Haastert, P. J. M.
(1988)
J. Cell Biol.
107,
521-528[Abstract/Free Full Text]
|
| 48.
|
Milne, J. L.,
and Devreotes, P. N.
(1993)
Mol. Biol. Cell
4,
283-292[Abstract]
|
| 49.
|
Garvey, J. S.,
Cramer, N. E.,
and Sussdorf, D. H.
(1977)
Methods in Immunology
, 3rd Ed.
, pp. 218-219, W. A. Benjamin, Inc., Reading, MA
|
| 50.
|
Noegel, A.,
Gerisch, G.,
Stadler, J.,
and Westphal, M.
(1986)
EMBO J.
5,
1473-1476[Medline]
[Order article via Infotrieve]
|
| 51.
|
Rowekamp, W.,
Pool, S.,
and Firtel, R. A.
(1980)
Cell
20,
495-505[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Podgorski, G. J.,
Franke, J.,
and Kessin, R. H.
(1986)
J. Gen. Microbiol.
132,
1043-1050[Abstract/Free Full Text]
|
| 53.
|
Yuen, I. S.,
Taphouse, C.,
Halfant, K. A.,
and Gomer, R. H.
(1991)
Development
113,
1375-1385[Abstract]
|
| 54.
|
Milne, J. L.,
and Coukell, M. B.
(1991)
J. Cell Biol.
112,
103-110[Abstract/Free Full Text]
|
| 55.
|
Wang, N.,
Soderbom, F.,
Anjard, C.,
Shaulsky, G.,
and Loomis, W. F.
(1999)
Mol. Cell. Biol.
19,
4750-4756[Abstract/Free Full Text]
|
| 56.
|
Sheikh, M.,
and Fornace, A. J.
(2000)
Leukemia
14,
1509-1513[CrossRef][Medline]
[Order article via Infotrieve]
|
| 57.
|
Mantovani, A.,
Locati, M.,
Vecchi, A.,
Sozzani, S.,
and Allavena, P.
(2001)
Trends Immunol.
22,
328-336[CrossRef][Medline]
[Order article via Infotrieve]
|
| 58.
|
Sower, L.,
Payne, D.,
Meyers, R.,
and Carney, D.
(1999)
Exp. Cell Res.
247,
422-431[CrossRef][Medline]
[Order article via Infotrieve]
|
| 59.
|
Sansom, D. M.
(2000)
Immunology
101,
169-177[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Gundersen, R. E.,
and Devreotes, P. N.
(1990)
Science
248,
591-593[Abstract/Free Full Text]
|
| 61.
|
Siu, C. H.,
Harris, T. J. C.,
Wong, E. F. S.,
Yang, C.,
Sesaki, H.,
and Wang, J.
(1997)
in
Dictyostelium: A Model System for Cell and Developmental Biology
(Maeda, Y.
, Inouye, K.
, and Takeuchi, I., eds)
, pp. 111-121, Universal Academy Press, Tokyo, Japan
|
| 62.
|
Loomis, W. F.
(1988)
Dev. Genet.
9,
549-560[CrossRef][Medline]
[Order article via Infotrieve]
|
| 63.
|
Siu, C. H.,
and Kamboj, R. K.
(1990)
Dev. Genet.
11,
377-387[CrossRef][Medline]
[Order article via Infotrieve]
|
| 64.
|
Stock, J.
(1996)
Science
274,
370-371[Free Full Text]
|
| 65.
|
Spiess, M.,
and Lodish, H.
(1986)
Cell
44,
177-185[CrossRef][Medline]
[Order article via Infotrieve]
|
| 66.
|
Alex, L. A.,
and Simon, M. I.
(1994)
Trends Genet.
10,
133-138[CrossRef][Medline]
[Order article via Infotrieve]
|
| 67.
|
Park, H.,
Saha, S.,
and Inouye, M.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6728-6732[Abstract/Free Full Text]
|
| 68.
|
Van Haastert, P. J. M.
(1985)
Biochim. Biophys. Acta
845,
254-260[Medline]
[Order article via Infotrieve]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Jang and R. H Gomer
Combining experiments and modelling to understand size regulation in Dictyostelium discoideum
J R Soc Interface,
August 6, 2008;
5(Suppl_1):
S49 - S58.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Brock, W. N. van Egmond, Y. Shamoo, R. D. Hatton, and R. H. Gomer
A 60-Kilodalton Protein Component of the Counting Factor Complex Regulates Group Size in Dictyostelium discoideum.
Eukaryot. Cell,
September 1, 2006;
5(9):
1532 - 1538.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Jang and R. H. Gomer
A Protein in Crude Cytosol Regulates Glucose-6-phosphatase Activity in Crude Microsomes to Regulate Group Size in Dictyostelium
J. Biol. Chem.,
June 16, 2006;
281(24):
16377 - 16383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Jang and R. H. Gomer
Exposure of Cells to a Cell Number-Counting Factor Decreases the Activity of Glucose-6-Phosphatase To Decrease Intracellular Glucose Levels in Dictyostelium discoideum
Eukaryot. Cell,
January 1, 2005;
4(1):
72 - 81.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ehrenman, G. Yang, W.-P. Hong, T. Gao, W. Jang, D. A. Brock, R. D. Hatton, J. D. Shoemaker, and R. H. Gomer
Disruption of Aldehyde Reductase Increases Group Size in Dictyostelium
J. Biol. Chem.,
January 9, 2004;
279(2):
837 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Brock, K. Ehrenman, R. Ammann, Y. Tang, and R. H. Gomer
Two Components of a Secreted Cell Number-counting Factor Bind to Cells and Have Opposing Effects on cAMP Signal Transduction in Dictyostelium
J. Biol. Chem.,
December 26, 2003;
278(52):
52262 - 52272.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Brock, R. D. Hatton, D.-V. Giurgiutiu, B. Scott, W. Jang, R. Ammann, and R. H. Gomer
CF45-1, a Secreted Protein Which Participates in Dictyostelium Group Size Regulation
Eukaryot. Cell,
August 1, 2003;
2(4):
788 - 797.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|